These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 29018367)

  • 1. Treatment of Comorbid Alcohol Dependence and Anxiety Disorder: Review of the Scientific Evidence and Recommendations for Treatment.
    Gimeno C; Dorado ML; Roncero C; Szerman N; Vega P; Balanzá-Martínez V; Alvarez FJ
    Front Psychiatry; 2017; 8():173. PubMed ID: 29018367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol use disorder with comorbid anxiety disorder: a case report and focused literature review.
    Mocanu V; Wood E
    Addict Sci Clin Pract; 2022 Nov; 17(1):62. PubMed ID: 36348370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical interventions for adults with comorbid alcohol use and depressive disorders: A systematic review and network meta-analysis.
    Grant S; Azhar G; Han E; Booth M; Motala A; Larkin J; Hempel S
    PLoS Med; 2021 Oct; 18(10):e1003822. PubMed ID: 34624018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for major depressive disorder and dysthymic disorder in patients with comorbid alcohol use disorders: a meta-analysis of placebo-controlled randomized trials.
    Iovieno N; Tedeschini E; Bentley KH; Evins AE; Papakostas GI
    J Clin Psychiatry; 2011 Aug; 72(8):1144-51. PubMed ID: 21536001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Australian guidelines for the treatment of alcohol problems: an overview of recommendations.
    Haber PS; Riordan BC; Winter DT; Barrett L; Saunders J; Hides L; Gullo M; Manning V; Day CA; Bonomo Y; Burns L; Assan R; Curry K; Mooney-Somers J; Demirkol A; Monds L; McDonough M; Baillie AJ; Clark P; Ritter A; Quinn C; Cunningham J; Lintzeris N; Rombouts S; Savic M; Norman A; Reid S; Hutchinson D; Zheng C; Iese Y; Black N; Draper B; Ridley N; Gowing L; Stapinski L; Taye B; Lancaster K; Stjepanović D; Kay-Lambkin F; Jamshidi N; Lubman D; Pastor A; White N; Wilson S; Jaworski AL; Memedovic S; Logge W; Mills K; Seear K; Freeburn B; Lea T; Withall A; Marel C; Boffa J; Roxburgh A; Purcell-Khodr G; Doyle M; Conigrave K; Teesson M; Butler K; Connor J; Morley KC
    Med J Aust; 2021 Oct; 215 Suppl 7():S3-S32. PubMed ID: 34601742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of alcohol use disorder and co-occurring PTSD.
    Taylor M; Petrakis I; Ralevski E
    Am J Drug Alcohol Abuse; 2017 Jul; 43(4):391-401. PubMed ID: 28010130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drinking to cope with negative emotions moderates alcohol use disorder treatment response in patients with co-occurring anxiety disorder.
    Anker JJ; Kushner MG; Thuras P; Menk J; Unruh AS
    Drug Alcohol Depend; 2016 Feb; 159():93-100. PubMed ID: 26718394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative utilization of pharmacotherapy for alcohol use disorder and other psychiatric disorders among U.S. Veterans Health Administration patients with dual diagnoses.
    Rubinsky AD; Chen C; Batki SL; Williams EC; Harris AH
    J Psychiatr Res; 2015 Oct; 69():150-7. PubMed ID: 26343607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders.
    Beaulieu S; Saury S; Sareen J; Tremblay J; Schütz CG; McIntyre RS; Schaffer A;
    Ann Clin Psychiatry; 2012 Feb; 24(1):38-55. PubMed ID: 22303521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment for dual diagnosis: a literature update and a proposal of intervention.
    Vitali M; Mistretta M; Alessandrini G; Coriale G; Romeo M; Attilia F; Rotondo C; Sorbo F; Pisciotta F; Attilia ML; Ceccanti M;
    Riv Psichiatr; 2018; 53(3):160-169. PubMed ID: 29912219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baclofen for alcohol use disorder.
    Minozzi S; Saulle R; Rösner S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012557. PubMed ID: 30484285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bidirectional Associations of Temporomandibular Joint Disorders with Major Depressive and Anxiety Disorders.
    Liou YJ; Bai YM; Tsai SJ; Chen TJ; Chen MH; Lo WL
    J Evid Based Dent Pract; 2023 Jun; 23(2):101860. PubMed ID: 37201980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid social anxiety disorder in patients with alcohol use disorder: A systematic review.
    Oliveira LM; Bermudez MB; Macedo MJA; Passos IC
    J Psychiatr Res; 2018 Nov; 106():8-14. PubMed ID: 30236640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sertraline treatment of comorbid posttraumatic stress disorder and alcohol dependence.
    Brady KT; Sonne SC; Roberts JM
    J Clin Psychiatry; 1995 Nov; 56(11):502-5. PubMed ID: 7592501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex differences in prevalence and comorbidity of alcohol and drug use disorders: results from wave 2 of the National Epidemiologic Survey on Alcohol and Related Conditions.
    Goldstein RB; Dawson DA; Chou SP; Grant BF
    J Stud Alcohol Drugs; 2012 Nov; 73(6):938-50. PubMed ID: 23036212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid alcohol use disorder in psychiatric MDD patients: A five-year prospective study.
    Holma M; Holma I; Isometsä E
    J Affect Disord; 2020 Apr; 267():283-288. PubMed ID: 32217228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and Novel Psychopharmacological Drugs for Anxiety Disorders.
    Bandelow B
    Adv Exp Med Biol; 2020; 1191():347-365. PubMed ID: 32002937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentations, social functioning, and treatment receipt among individuals with comorbid life-time PTSD and alcohol use disorders versus drug use disorders: findings from NESARC-III.
    Simpson TL; Rise P; Browne KC; Lehavot K; Kaysen D
    Addiction; 2019 Jun; 114(6):983-993. PubMed ID: 30694592
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.